15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain.

Copy number variations (CNVs) within human 15q11.2-13.3 show reduced penetrance and variable expressivity in a range of neurologic disorders. Therefore, characterizing 15q11.2-13.3 chromatin structure is important for understanding the regulation of this locus during normal neuronal development. Deletion of the Prader-Willi imprinting center (PWS-IC) within 15q11.2-13.3 disrupts long-range imprinted gene expression resulting in Prader-Willi syndrome. Previous results establish that MeCP2 binds to the PWS-IC and is required for optimal expression of distal GABRB3 and UBE3A. To examine the hypothesis that MeCP2 facilitates 15q11.2-13.3 transcription by linking the PWS-IC with distant elements, chromosome capture conformation on chip (4C) analysis was performed in human SH-SY5Y neuroblastoma cells. SH-SY5Y neurons had 2.84-fold fewer 15q11.2-13.3 PWS-IC chromatin interactions than undifferentiated SH-SY5Y neuroblasts, revealing developmental chromatin de-condensation of the locus. Out of 68 PWS-IC interactions with15q11.2-13.3 identified by 4C analysis and 62 15q11.2-13.3 MeCP2-binding sites identified by previous ChIP-chip studies, only five sites showed overlap. Remarkably, two of these overlapping PWS-IC- and MeCP2-bound sites mapped to sites flanking CHRNA7 (cholinergic receptor nicotinic alpha 7) encoding the cholinergic receptor, nicotinic, alpha 7. PWS-IC interaction with CHRNA7 in neurons was independently confirmed by fluorescent in situ hybridization analysis. Subsequent quantitative transcriptional analyses of frontal cortex from Rett syndrome and autism patients revealed significantly reduced CHRNA7 expression compared with controls. Together, these results suggest that transcription of CHRNA7 is modulated by chromatin interactions with the PWS-IC. Thus, loss of long-range chromatin interactions within 15q11.2-13.3 may contribute to multiple human neurodevelopmental disorders.

[1]  D. Rojas,et al.  Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia , 2011, Biological Psychiatry.

[2]  E. Eichler,et al.  Phenotypic variability and genetic susceptibility to genomic disorders. , 2010, Human molecular genetics.

[3]  L. Gierasch,et al.  Unique physical properties and interactions of the domains of methylated DNA binding protein 2. , 2010, Biochemistry.

[4]  Robert S. Illingworth,et al.  Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. , 2010, Molecular cell.

[5]  P. Stankiewicz,et al.  A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes , 2009, Nature Genetics.

[6]  J. LaSalle,et al.  Evolving role of MeCP2 in Rett syndrome and autism. , 2009, Epigenomics.

[7]  J. LaSalle,et al.  Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size , 2009, Human molecular genetics.

[8]  J. Disterhoft,et al.  Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. , 2009, Nature neuroscience.

[9]  P. Stankiewicz,et al.  Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders , 2009, Journal of Medical Genetics.

[10]  E. Levin,et al.  Nicotinic α7- or β2-containing receptor knockout: Effects on radial-arm maze learning and long-term nicotine consumption in mice , 2009, Behavioural Brain Research.

[11]  Christian E Elger,et al.  15q13.3 microdeletions increase risk of idiopathic generalized epilepsy , 2009, Nature Genetics.

[12]  R. Freedman,et al.  Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers , 2009, Journal of Molecular Neuroscience.

[13]  E. Nestler,et al.  Epigenetics in the Nervous System , 2008, The Journal of Neuroscience.

[14]  M. Daly,et al.  Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders , 2008, Journal of Medical Genetics.

[15]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[16]  B. Horsthemke,et al.  Mechanisms of imprinting of the Prader–Willi/Angelman region , 2008, American journal of medical genetics. Part A.

[17]  Stephen T. C. Wong,et al.  MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.

[18]  Marwan Shinawi,et al.  Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster , 2008, Nature Genetics.

[19]  D. Geschwind,et al.  Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.

[20]  Yu Wang,et al.  A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures , 2008, Nature Genetics.

[21]  M. Bieda,et al.  Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes , 2007, Proceedings of the National Academy of Sciences.

[22]  W. D. Laat,et al.  An evaluation of 3C-based methods to capture DNA interactions , 2007, Nature Methods.

[23]  R. Ghosh,et al.  MeCP2-Chromatin Interactions Include the Formation of Chromatosome-like Structures and Are Altered in Mutations Causing Rett Syndrome* , 2007, Journal of Biological Chemistry.

[24]  R. Ohlsson,et al.  The 4C technique: the 'Rosetta stone' for genome biology in 3D? , 2007, Current opinion in cell biology.

[25]  Eric J. Nestler,et al.  Epigenetic regulation in psychiatric disorders , 2007, Nature Reviews Neuroscience.

[26]  J. LaSalle,et al.  15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. , 2007, Human molecular genetics.

[27]  B. Steensel,et al.  Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture–on-chip (4C) , 2006, Nature Genetics.

[28]  R. Ghosh,et al.  Multiple Modes of Interaction between the Methylated DNA Binding Protein MeCP2 and Chromatin , 2006, Molecular and Cellular Biology.

[29]  J. LaSalle,et al.  Reduced MeCP2 Expression is Frequent in Autism Frontal Cortex and Correlates with Aberrant MECP2 Promoter Methylation , 2006, Epigenetics.

[30]  D. Collier,et al.  Performance deficit of α7 nicotinic receptor knockout mice in a delayed matching‐to‐place task suggests a mild impairment of working/episodic‐like memory , 2006, Genes, brain, and behavior.

[31]  P. Wade,et al.  MBD family proteins: reading the epigenetic code , 2006, Journal of Cell Science.

[32]  John L Bradshaw,et al.  Visuospatial processing and the function of prefrontal-parietal networks in autism spectrum disorders: a functional MRI study. , 2006, The American journal of psychiatry.

[33]  J. LaSalle,et al.  Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. , 2006, Human molecular genetics.

[34]  Mark Bieda,et al.  Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. , 2006, Genome research.

[35]  R. Jaenisch,et al.  Postnatal Loss of Methyl-CpG Binding Protein 2 in the Forebrain is Sufficient to Mediate Behavioral Aspects of Rett Syndrome in Mice , 2006, Biological Psychiatry.

[36]  S. Nelson,et al.  The Disease Progression of Mecp2 Mutant Mice Is Affected by the Level of BDNF Expression , 2006, Neuron.

[37]  E. Keefer,et al.  A segment of the Mecp2 promoter is sufficient to drive expression in neurons. , 2005, Human molecular genetics.

[38]  T. Portis,et al.  A nonimprinted Prader-Willi Syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted pws loci do not alter genome-wide mRNA levels. , 2005, Genomics.

[39]  Rodney C Samaco,et al.  Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. , 2005, Human molecular genetics.

[40]  Jan-Fang Cheng,et al.  Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome , 2005, Nature Genetics.

[41]  D. Horn,et al.  Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader–Willi syndrome , 2005, Human Genetics.

[42]  Wolf Reik,et al.  Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops , 2004, Nature Genetics.

[43]  H. Zoghbi,et al.  Rett Syndrome: A Prototypical Neurodevelopmental Disorder , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[44]  Rodney C. Samaco,et al.  Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. , 2004, Human molecular genetics.

[45]  J. Eubanks,et al.  The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. , 2003, Journal of neurobiology.

[46]  J. Buxbaum,et al.  Association between a GABRB3 polymorphism and autism , 2002, Molecular Psychiatry.

[47]  R. Nicholls,et al.  Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. , 2001, Annual review of genomics and human genetics.

[48]  F. Volkmar,et al.  Brief Report: Interrater Reliability of Clinical Diagnosis and DSM-IV Criteria for Autistic Disorder: Results of the DSM-IV Autism Field Trial , 2000, Journal of autism and developmental disorders.

[49]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[50]  D. Bertrand,et al.  Localization of mRNA for CHRNA7 in human fetal brain. , 1999, Neuroreport.

[51]  K. Blennow,et al.  Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. , 1999, Neuroreport.

[52]  D. J. Driscoll,et al.  Imprinting-mutation mechanisms in Prader-Willi syndrome. , 1999, American journal of human genetics.

[53]  J. Gault,et al.  Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). , 1998, Genomics.

[54]  S. Leff,et al.  A mouse model for Prader-Willi syndrome imprinting-centre mutations , 1998, Nature Genetics.

[55]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[56]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[57]  M. Cuccaro,et al.  Autism and maternally derived aberrations of chromosome 15q. , 1998, American journal of medical genetics.

[58]  A. Beaudet,et al.  Mice Deficient in the α7 Neuronal Nicotinic Acetylcholine Receptor Lack α-Bungarotoxin Binding Sites and Hippocampal Fast Nicotinic Currents , 1997, The Journal of Neuroscience.

[59]  L Kruglyak,et al.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Lalande,et al.  UBE3A/E6-AP mutations cause Angelman syndrome , 1996, Nature Genetics.

[61]  A. Beaudet,et al.  Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. , 1997, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[62]  R Anand,et al.  Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. , 1994, Molecular pharmacology.

[63]  S. Heinemann,et al.  Molecular cloning and chromosomal localization of the human α7-nicotinic receptor subunit gene (CHRNA7) , 1994 .

[64]  M. Butler,et al.  Prader-Willi syndrome: consensus diagnostic criteria. , 1993, Pediatrics.

[65]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[66]  U Hammerling,et al.  Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. , 1990, Acta physiologica Scandinavica. Supplementum.